Core Clinical Centers
Fosun Health brings together 76 provincial and municipal key specialties across 20 departments and specialty centers at its hospitals in China, covering areas from precision oncology and orthopedics to women & children, TCM, and cardiovascular care. These centers are built around international-standard, full-cycle care pathways.
Departments
Oncology Center Overview
Fosun Health, represented by the Cancer Centers of Foshan Fosun Chancheng Hospital and Guangzhou Fosun Chancheng Hospital, has established a modern cancer prevention and treatment network integrating “Full-Cycle Management, One-Stop Service, and Precision Diagnosis.”
Specialty Introduction
- Scale of Resources: Equipped with over 440 open beds and multiple specialized wards, the network possesses the capacity to admit and treat a large number of patients with diverse complex tumors.
- Clinical Model: The network fully implements the international-standard Multi-Disciplinary Team (MDT) model, integrating surgery, chemotherapy, and radiotherapy with cutting-edge technologies from around the world.
- State-of-the-Art Equipment: The network is equipped with advanced radiotherapy and minimally invasive interventional systems, including the CyberKnife M6 (one of only approximately 300 units worldwide) and the next-generation Varian VitalBeam linear accelerator.
- International Certification: The Oncology Center of Foshan Fosun Chancheng Hospital was the first in Asia to be certified as a member of the Radiosurgery Society (RSS) in 2021.
- National Patent: The center developed the original SCART (Stereotactic Centralized Ablative Radiation Therapy) technology, which has been granted a Chinese national patent.
- Regional Benchmark: The center is recognized as a “14th Five-Year Plan” Medical Key Specialty in Chancheng District, Foshan, and serves as the chairing institution of the Oncology Subcommittee of the Baiyun District Medical Association, Guangzhou.
Featured Treatment Programs
Our signature treatment programs include robotic surgery, precision radiotherapy, minimally invasive interventions, CAR-T cell therapy, and Tumor Treating Fields. Together, we provide one-stop, integrated oncology care that combines advanced medical technologies with personalized, patient-centered support seamlessly.
| Category | Disease Scope | Core Treatment Capabilities |
|---|---|---|
| Non-CNS Solid Tumors | Lung, breast, ovarian, endometrial, colorectal, gastric, esophageal, pancreatic, prostate, liver, thyroid, melanoma, ocular adnexal / intraocular tumors, bladder, bone and other solid tumors |
|
| Central Nervous System Tumors | Glioma and other CNS tumors |
|
| Hematologic Malignancies | Leukemia, lymphoma, multiple myeloma and other hematologic malignancies |
|
Cheaper · Quicker · Better
-
Cheaper
Benefiting from China's drug price policies and competitive pharmaceutical market, patients in China can often access leading oncology medicines at far more affordable prices. For example, based on public list prices, Tevimbra (tislelizumab) in China is priced at less than 5% of the U.S. list price.
-
Quicker
Patients in China may gain earlier access to selected China-developed immunotherapies, precision therapies targeting mutations more commonly seen in Asian patients, and next-generation ADCs. In 2024, China-headquartered companies initiated 39%[Source: IQVIA] of global oncology clinical trials, ranking No.1 worldwide. Fosun Health provides access to China's Phase III clinical trial resources for patients seeking options beyond standard treatment.
-
Better
Cancer treatment can be demanding. Our integrative TCM program complements primary oncology treatment and focuses on two evidence-based goals: reducing treatment-related toxicity and improving treatment tolerance.
Key Statistics
-
60,000+
Annual oncology patient admissions across our major international hospitals in 2025
-
17,000+
Cumulative TACE procedures performed at Guangzhou Fosun Chancheng Hospital alone from 2023 to 2025, with international patients accounting for more than 10% of the total
-
1,000+
Successful CyberKnife treatments performed, demonstrating world-class precision radiotherapy expertise
-
29.3%
Five-year survival rate achieved for patients with Glioblastoma Multiforme (GBM) receiving combined TTFields therapy, compared with the baseline of 4.7%
Core Medical Team
Our senior medical team brings together specialists from China and the U.S., covering radiation oncology, interventional oncology, hematology, and surgical oncology. Full team details are available in the Experts Center.
Experts Center-

Prof. Yang Jun
Developer of North American CyberKnife Quality Control Standards
Over 6,000 CyberKnife Treatment Cases
Director of the Precision Tumor Diagnosis and Treatment Center, Foshan Fosun Chancheng Hospital -

Prof. Luo Pengfei
Pioneering Figure in Chinese Interventional Radiology
Creator of the “Luo Pengfei Procedure Oncology Therapy”
Recipient of the Special Allowance for Expert Contributions from the State Council of the People’s Republic of China -

Prof. Chen Tao
Postdoctoral Fellow | Expert in Tumor Immunotherapy Adviser, Tumor Immunotherapy Committee, Guangdong Clinical Oncology Association Member, Cancer Chemotherapy Committee, China Anti-Cancer Association Member, Hematologic Translational Medicine Committee, China Anti-Cancer Association Vice Chair, Cancer Prevention & Rehabilitation Committee, Guangdong Health Care Association Vice Chair, Lymphoma Prevention & Control Committee, Fujian Preventive Medical Association
-

Prof. Zeng Zongyuan
Chief Physician, Recipient of the Special Government Allowance of the State Council of China, Guangzhou Fosun Chancheng Hospital With over 60 years of experience in oncology research, Professor Zeng is a renowned expert in head and neck tumors, particularly laryngeal and oral cancers. He remains the Chief Expert for laryngeal cancer in Guangdong Province. Famous for his "Zero Bleeding" technique, he pioneered innovative suturing methods to prevent hemorrhage. He has achieved exceptional success in surgeries for thyroid tumors, parotid gland tumors, and facial/neck hemangiomas.
Showing 4 of 20 doctors
Oncology Center Overview
Fosun Health, represented by the Cancer Centers of Foshan Fosun Chancheng Hospital and Guangzhou Fosun Chancheng Hospital, has established a modern cancer prevention and treatment network integrating “Full-Cycle Management, One-Stop Service, and Precision Diagnosis.”
Specialty Introduction
- Scale of Resources: Equipped with over 440 open beds and multiple specialized wards, the network possesses the capacity to admit and treat a large number of patients with diverse complex tumors.
- Clinical Model: The network fully implements the international-standard Multi-Disciplinary Team (MDT) model, integrating surgery, chemotherapy, and radiotherapy with cutting-edge technologies from around the world.
- State-of-the-Art Equipment: The network is equipped with advanced radiotherapy and minimally invasive interventional systems, including the CyberKnife M6 (one of only approximately 300 units worldwide) and the next-generation Varian VitalBeam linear accelerator.
- International Certification: The Oncology Center of Foshan Fosun Chancheng Hospital was the first in Asia to be certified as a member of the Radiosurgery Society (RSS) in 2021.
- National Patent: The center developed the original SCART (Stereotactic Centralized Ablative Radiation Therapy) technology, which has been granted a Chinese national patent.
- Regional Benchmark: The center is recognized as a “14th Five-Year Plan” Medical Key Specialty in Chancheng District, Foshan, and serves as the chairing institution of the Oncology Subcommittee of the Baiyun District Medical Association, Guangzhou.
Featured Treatment Programs
Our signature treatment programs include robotic surgery, precision radiotherapy, minimally invasive interventions, CAR-T cell therapy, and Tumor Treating Fields. Together, we provide one-stop, integrated oncology care that combines advanced medical technologies with personalized, patient-centered support seamlessly.
| Category | Disease Scope | Core Treatment Capabilities |
|---|---|---|
| Non-CNS Solid Tumors | Lung, breast, ovarian, endometrial, colorectal, gastric, esophageal, pancreatic, prostate, liver, thyroid, melanoma, ocular adnexal / intraocular tumors, bladder, bone and other solid tumors |
Surgery, including Da Vinci robotic surgery where appropriate Radiotherapy — CyberKnife and linear accelerator Interventional therapy — TACE and ablation Endocrine therapy, targeted therapy, immunotherapy, and chemotherapy HIPEC for ovarian cancer · Integrated TCM · Nutrition · Pain management · Rehabilitation |
| Central Nervous System Tumors | Glioma and other CNS tumors |
Surgery and radiotherapy (CyberKnife, linear accelerator) Tumor Treating Fields (TTF) for selected glioblastoma patients Chemotherapy, targeted therapy and immunotherapy in selected cases Anti-epileptic treatment · Integrated TCM · Nutrition support |
| Hematologic Malignancies | Leukemia, lymphoma, multiple myeloma and other hematologic malignancies |
CAR-T cell therapy — including the world's first approved solid-tumor CAR-T Targeted therapy and immunotherapy for selected types Chemotherapy and radiotherapy for selected localized disease Integrated TCM · Nutrition support |
Cheaper · Quicker · Better
-
Cheaper
Benefiting from China's drug price policies and competitive pharmaceutical market, patients in China can often access leading oncology medicines at far more affordable prices. For example, based on public list prices, Tevimbra (tislelizumab) in China is priced at less than 5% of the U.S. list price.
-
Quicker
Patients in China may gain earlier access to selected China-developed immunotherapies, precision therapies targeting mutations more commonly seen in Asian patients, and next-generation ADCs. In 2024, China-headquartered companies initiated 39%[Source: IQVIA] of global oncology clinical trials, ranking No.1 worldwide. Fosun Health provides access to China's Phase III clinical trial resources for patients seeking options beyond standard treatment.
-
Better
Cancer treatment can be demanding. Our integrative TCM program complements primary oncology treatment and focuses on two evidence-based goals: reducing treatment-related toxicity and improving treatment tolerance.
Key Statistics
-
60,000+
Annual oncology patient admissions across our major international hospitals in 2025
-
17,000+
Cumulative TACE procedures performed at Guangzhou Fosun Chancheng Hospital alone from 2023 to 2025, with international patients accounting for more than 10% of the total
-
1,000+
Successful CyberKnife treatments performed, demonstrating world-class precision radiotherapy expertise
-
29.3%
Five-year survival rate achieved for patients with Glioblastoma Multiforme (GBM) receiving combined TTFields therapy, compared with the baseline of 4.7%
Core Medical Team
Our senior medical team brings together specialists from China and the U.S., covering radiation oncology, interventional oncology, hematology, and surgical oncology. Full team details are available on the Experts Center ↗.
-

Prof. Yang Jun
Developer of North American CyberKnife Quality Control Standards
Over 6,000 CyberKnife Treatment Cases
Director of the Precision Tumor Diagnosis and Treatment Center, Foshan Fosun Chancheng Hospital -

Prof. Luo Pengfei
Pioneering Figure in Chinese Interventional Radiology
Creator of the “Luo Pengfei Procedure Oncology Therapy”
Recipient of the Special Allowance for Expert Contributions from the State Council of the People’s Republic of China -

Prof. Chen Tao
Postdoctoral Fellow | Expert in Tumor Immunotherapy Adviser, Tumor Immunotherapy Committee, Guangdong Clinical Oncology Association Member, Cancer Chemotherapy Committee, China Anti-Cancer Association Member, Hematologic Translational Medicine Committee, China Anti-Cancer Association Vice Chair, Cancer Prevention & Rehabilitation Committee, Guangdong Health Care Association Vice Chair, Lymphoma Prevention & Control Committee, Fujian Preventive Medical Association
-

Prof. Zeng Zongyuan
Chief Physician, Recipient of the Special Government Allowance of the State Council of China, Guangzhou Fosun Chancheng Hospital With over 60 years of experience in oncology research, Professor Zeng is a renowned expert in head and neck tumors, particularly laryngeal and oral cancers. He remains the Chief Expert for laryngeal cancer in Guangdong Province. Famous for his "Zero Bleeding" technique, he pioneered innovative suturing methods to prevent hemorrhage. He has achieved exceptional success in surgeries for thyroid tumors, parotid gland tumors, and facial/neck hemangiomas.
-

Prof. Ye Gang
Chief Expert, Department of Medical Oncology,US Board-Certified Physician in Internal Medicine, Hematology, and Medical Oncology Former Director, Medical Oncology & Multidisciplinary Team (MDT) Leader, Boao Evergrande International Hospital & Brigham and Women’s Hospital
-

Prof. Zhou Zejian
International Center for Minimally Invasive Oncology
Chief Physician -

Prof. Han Liangfu
Chief Medical Expert, Foshan Chancheng Medical Oncology Precision Radiotherapy Center Member, the American Society for Radiation Oncology (ASTRO) Member, the Executive Committee, Chinese Radiation Oncology Group (CRTOG)
-

Prof. Wang Enmin
China's First Gamma Knife Surgery Doctorate Holder
Vice Chairman, Neuro-Radiosurgery Committee, World Chinese Neurosurgical Society
Chief Editor of China's most authoritative CyberKnife monograph "CyberKnife Radiosurgery" -

Prof. Ye Sheng
Chief Physician, Guangzhou Fosun Chancheng Hospital
Professor Ye has more than 30 years of clinical experience in medical oncology and specializes in the comprehensive diagnosis and treatment of lung cancer, gastric cancer, colorectal cancer, and liver cancer. -

Dr. Lu Qiuxia
Medical Director, Medical Oncology Precision Diagnosis and Treatment Center National-level Mentor, Radiation Oncology Residency Training Chief, China-U.S. MDT (Multidisciplinary Team) Program
-

Dr. Gong Wei
Director, the Thoracic Oncology Specialty, Oncology Precision Diagnosis and Treatment Center Standing Committee Member, the Radiotherapy Committee, Guangdong Association of Chinese Integrative Medicine Standing Committee Member, the Radiotherapy Committee, Guangzhou Anti-Cancer Association Member, the Radiotherapy Committee, Guangdong Clinical Medical Association
-

Prof. Chen Bing guang
2018-2020 “Lingnan Famous Doctor” in Oncology (Guangdong Province) Vice Chairman, the Chinese Colorectal Cancer MDT Alliance Director, the Abdominopelvic Specialty, the Oncology Precision Radiotherapy Center, Foshan Fosun Chancheng Hospital
-

Prof. Wang Jian
Chief Physician, Tumor Radiation and Interventional Department Inheritor of the Cheng's Microneedle Technique
-

Prof. Tang Rijie
Chief Physician, Third Oncology Department, Guangzhou Fosun Chancheng Hospital Professor / Doctoral Supervisor
-

Prof. Jia Yun
Chief Physician, Department of Oncology (Zone III) , Guangzhou Fosun Chancheng Hospital Adjunct Professor & Postdoctoral Co-Supervisor, Southern Medical University
-

Dr. Cui Zhe
Chief Physician, Department of Medical Oncology, Guangzhou Fosun Chancheng Hospital Expert in Interventional & Minimally Invasive Oncology
-

Dr. Zhang Dongxing
Former Leading Figure and Chief Expert in Oncology, PLA No. 150 Central Hospital Chief Physician, Second Oncology Department, Guangzhou Fosun Chancheng Hospital
-

Prof. Zhong Guanghua
Associate Chief Physician, Department of Hematology and Oncology Associate Professor, Guangzhou University of Chinese Medicine
-

Dr. Peng Qirong
Associate Chief Physician, MD, Oncology Specialist
-

Dr. Ou Xiaobing
Attending Physician, Oncology Specialist
Choosing a Clinical Center in China
What are the Core Clinical Centers of Fosun Health?
Fosun Health operates 20 departments and specialty centers across its hospitals in China — Oncology Center, Orthopedics, Traditional Chinese Medicine, Cardiovascular Medicine, Reproductive Medicine, Women & Children's Department, Ophthalmology, Neurology, Hepatobiliary Surgery, Nephrology, Plastic Surgery, Rehabilitation Medicine, Wound Repair, Breast and Thyroid Surgery, Integrated Medicine for Chronic Diseases, Health Management, Brain, Urology, Medical Checkup Center and Intensive Care Medicine — supported by 76 provincial and municipal key specialties and 7 GCP-certified hospitals.
Which center should I choose for cancer treatment?
Start with the Oncology Center, anchored at Foshan Fosun Chancheng Hospital and Guangzhou Fosun Chancheng Hospital. It covers non-CNS solid tumors, central nervous system tumors, and hematologic malignancies, with 60,000+ annual oncology admissions across our major international hospitals in 2025.
What makes the Fosun Health Oncology Center world-class?
It combines full-cycle MDT care with CyberKnife M6 radiosurgery (one of only approximately 300 units worldwide, with 6,000+ cases performed at Foshan Chancheng), the Varian VitalBeam linear accelerator, Da Vinci robotic surgery, CAR-T cell therapy, and Tumor Treating Fields. The Oncology Center of Foshan Fosun Chancheng Hospital was the first in Asia to be certified by the Radiosurgery Society (RSS) in 2021.
How do I choose a center for non-cancer conditions?
Use the Departments menu on this page. Each department opens an on-page profile with its official specialty introduction and featured treatment programs. A link at the bottom of each profile leads to the full department page on hospitals.fosunhealth.com. If you are unsure, send us your reports for a free evaluation, and our specialists will recommend the appropriate center and doctor for your case.
Do these clinical centers accept international patients?
Yes. All departments serve international patients through our network-wide international patient teams, with multilingual support, direct billing with 70+ insurers, and access to 52 innovative international medicines and devices under the Hong Kong and Macau Drug and Device Access Policy at designated hospitals.
Can I get a second opinion before travelling to China?
Yes. Begin with a remote video consultation or medical record review through our 9 licensed internet hospitals. Specialists review your scans and records, recommend the appropriate center and doctor, and our international team coordinates scheduling, visa, and travel arrangements.
Find the Right Center for Your Condition
Send us your reports for a free review — our specialists will recommend the right clinical center and doctor for your case.
Book a Consultation Start with a Video Consultation Browse Conditions We Treat
